The United States Patent and Trademark Office (USPTO) has granted patent US12582659B2 to ALL LABS, INC. The patent covers a liquid stimulant composition comprising water, caffeine at a concentration of at least 0.04 g/mL, and a tyrosine-based compound that enhances caffeine solubility. A method for increasing caffeine solubility is also included.

This patent grant is primarily an intellectual property matter. While it relates to pharmaceutical compositions, it does not impose new regulatory obligations or compliance requirements on drug manufacturers or pharmaceutical companies. Compliance officers should note this as a development in the intellectual property landscape for stimulant compositions.